logo
🎀
Pathology Lesson · Breast Pathology

Fibroadenoma

Lesson 14 of 15 · Detailed pathology

PathologyBreast Pathology

Points of Recognition

  • 1Biphasic proliferation: glands + stroma
  • 2Intracanalicular pattern (compressed slits) or pericanalicular (open glands)
  • 3Stroma may be myxoid or hyalinised
  • 4Well-circumscribed border
  • 5Absence of stromal overgrowth or atypia (distinguishes from phyllodes)
Fibroadenoma slide 1
Low magnification
Fibroadenoma slide 2
High magnification

Image reference: PathologyOutlines.com

View topic

Detailed Pathology

Definition

Fibroadenoma is the most common benign breast tumour in women under 30. It is a biphasic tumour composed of epithelial (acinar and ductal) and stromal (fibroblastic) elements. Two histological patterns exist: pericanalicular (fibrous stroma encircles rounded acini) and intracanalicular (fibrous stroma compresses ducts into elongated slit-like clefts).

General / Essential Features

  • Biphasic tumour: epithelial + fibroblastic stromal components
  • Small acini and duct-like structures resembling normal breast tissue
  • Fibrous stroma arranged around and between acini
  • Epithelial clefts (slit-like) formed by fibrous compression — intracanalicular pattern
  • Benign epithelium: regular nuclei, no atypia, no mitoses
  • Well-circumscribed; usually encapsulated

Sites

  • Upper outer quadrant of the breast (most common quadrant for all breast lesions)
  • Typically solitary; multiple in 10–15% (giant fibroadenoma in juveniles)
  • No specific lobar distribution

Pathophysiology

Fibroadenomas arise from the terminal duct–lobular unit (TDLU). Oestrogenic stimulation during reproductive years drives growth; lesions often enlarge during pregnancy and regress post-menopause. MED12 mutations (as in uterine fibroids) have been identified. Giant juvenile fibroadenoma occurs in adolescents and can be rapidly growing.

Etiology

  • Hormonal: oestrogen-sensitive — common in reproductive years
  • MED12 somatic mutations
  • Black women of Caribbean or African descent: higher incidence of multiple/giant fibroadenomas
  • Cyclosporine use after renal transplant — associated with giant fibroadenoma

Clinical Features

  • Smooth, mobile, well-defined, non-tender breast lump ('breast mouse')
  • Usually 1–3 cm; may be multiple
  • No skin changes, no nipple discharge
  • Triple assessment: clinical + ultrasound + FNAC/core biopsy
  • Malignant transformation extremely rare (<0.1%)

Diagnosis

  • Ultrasound: well-defined, homogeneous, hypoechoic lesion with gentle lobulations
  • FNAC / core biopsy: confirms benign biphasic histology
  • Mammography: in women over 35 — calcified fibroadenoma ('popcorn' calcification)
  • MRI: for multiple lesions or in high-risk patients

Treatment

  • Conservative management for lesions <3 cm with confirmed benign histology
  • Surgical excision: for >3 cm, growing, or patient anxiety
  • Vacuum-assisted biopsy excision: ultrasound-guided, no scar
  • Annual review: to monitor size and exclude interval change

Video Lesson

References

  • Kumar V, Abbas AK, Aster JC. Robbins & Cotran Pathologic Basis of Disease (10th ed.). Elsevier. 2020.
  • Harsh Mohan. Textbook of Pathology (8th ed.). Jaypee Brothers. 2019.
  • Bancroft JD, Layton C. Bancroft's Theory and Practice of Histological Techniques (8th ed.). Elsevier. 2019.
  • PathologyOutlines.com. (2024). View topic

Ready to test yourself?

Apply what you've learned in the Pathology Spotting Test

Take the Test